. Author manuscript; available in PMC: 2021 Dec 9.

Published in final edited form as: Clin Cancer Res. 2014 May 29;20(14):3753–3762. doi: 10.1158/1078-0432.CCR-13-3042

Table 2.

Histological and immunohistochemical analysis of oral MM from dogs included in the study

	Threshold	Overall population	Group I	Group II	Group III	Group II+ III
Ki67 ^a	< 19.5	18.5% (27/33)^b	9.1% (11/14)^b	18.2% (11/13)^b	40.0% (5/6)^b	25.0% (16/19)^b
Ki67 ^a	≥ 19.5	81.5% (27/33)	90.9% (11/14)	81.8% (11/13)	60.0% (5/6)	75.0% (16/19)
Mitotic Index (MI) ^a	< 4/10 hpf	3 (9.1%)	3 (21.4%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Mitotic Index (MI) ^a	≥ 4/10 hpf	30 (90.9%)	11 (78.6%)	13 (100.0%)	6 (100.0%)	19 (100.0%)
Nuclear Atypia (PLEOM) ^a	< 30.0% ≥ 30.0%	14 (42.4%) 19 (57.6%)	5 (35.7%) 9 (64.3%)	5 (38.5%) 8 (61.5%)	4 (66.7%) 2 (33.3%)	9 (47.4%) 10 (52.6%)

prognostic factors for cMM as proposed by Bergin et al. (32), Smedley et al. (33), Ottnod et al. (25)

number of patients for which the data were available